Amdocs Stock Analysis

DOX -  USA Stock  

USD 84.88  3.42  4.20%

The current indifference towards the small price fluctuations of Amdocs Limited could raise concerns from investors as the firm is trading at a share price of 84.88 on 920,764 in volume. The company management teams did not add any value to Amdocs investors in May. However, most investors can still diversify their portfolios with Amdocs Limited to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.68. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
Continue to Investing Opportunities.
  
Refresh
The Amdocs stock analysis report makes it easy to digest most publicly released information about Amdocs and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Amdocs Stock analysis module also helps to analyze the Amdocs price relationship with some important fundamental indicators such as market cap and management efficiency.

Amdocs Stock Analysis Notes

About 96.0% of the company shares are held by institutions such as insurance companies. The book value of Amdocs was currently reported as 28.77. The company has Price/Earnings To Growth (PEG) ratio of 1.24. Amdocs Limited recorded earning per share (EPS) of 5.32. The entity next dividend is scheduled to be issued on the 30th of March 2022. The firm had 1:4 split on the December 1, 2003. Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 29000 people. To learn more about Amdocs Limited call Eli Gelman at 314 212 7000 or check out https://www.amdocs.com.

Amdocs Quarterly Cost of Revenue

741.26 Million

Share

Amdocs Limited Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Amdocs' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Amdocs Limited or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 96.0% of the company shares are held by institutions such as insurance companies
Latest headline from stocknews.com: ANTM 5 Safe and Cheap Stocks to Buy Amid the Market Volatility - StockNews.com

Amdocs Limited Upcoming and Recent Events

Earnings reports are used by Amdocs to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Amdocs previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report1st of February 2022
Next Financial Report11th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End1st of November 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Amdocs Largest EPS Surprises

Earnings surprises can significantly impact Amdocs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1999-01-25
1998-12-310.090.10.0111 
1998-11-11
1998-09-300.050.060.0120 
2003-01-22
2002-12-310.180.20.0211 
View All Earnings Estimates

Amdocs SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Amdocs prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Amdocs investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Amdocs Limited specific information freely available to individual and institutional investors to make a timely investment decision.
24th of May 2022
Other Events
View
11th of May 2022
Other Events
View
14th of February 2022
Other Events
View
10th of February 2022
Unclassified Corporate Event
View
9th of February 2022
Unclassified Corporate Event
View
2nd of February 2022
Unclassified Corporate Event
View
1st of February 2022
Other Events
View
22nd of December 2021
Other Events
View

Amdocs Thematic Classifications

In addition to having Amdocs stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Israel Wall Street IdeaIsrael Wall Street
Large Israel companies traded on major USA exchanges
Business Services IdeaBusiness Services
USA Equities from Business Services industry as classified by Fama & French

Amdocs Market Capitalization

The company currently falls under 'Mid-Cap' category with total capitalization of 9.76 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amdocs's market, we take the total number of its shares issued and multiply it by Amdocs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Amdocs Profitablity

Amdocs' profitability indicators refer to fundamental financial ratios that showcase Amdocs' ability to generate income relative to its revenue or operating costs. If, let's say, Amdocs is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Amdocs' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Amdocs' profitability requires more research than a typical breakdown of Amdocs' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 12.13 %, which may imply that it executes well on its competitive polices and has reasonable control over its expenses and variable costs. This is very large. In the same way, it shows Net Operating Margin of 14.36 %, which entails that for every 100 dollars of revenue, it generated 0.14 of operating income.
Last ReportedProjected for 2022
Return on Investment 12.53  12.42 
Return on Average Assets 0.12  0.11 
Return on Average Equity 0.22  0.19 
Return on Invested Capital 0.33  0.44 
Return on Sales 0.22  0.19 

Management Efficiency

The entity has Return on Asset of 5.76 % which means that on every $100 spent on asset, it made $5.76 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 14.03 %, implying that it generated $14.03 on every 100 dollars invested. Amdocs management efficiency ratios could be used to measure how well amdocs limited manages its routine affairs as well as how well it operates its assets and liabilities. Return on Invested Capital is likely to rise to 0.44 in 2022, whereas Return on Investment is likely to drop 12.42 in 2022. Amdocs Tax Assets are fairly stable at the moment as compared to the past year. Amdocs reported Tax Assets of 135.66 Million in 2021. Revenue to Assets is likely to rise to 0.60 in 2022, whereas Total Assets are likely to drop slightly above 7 B in 2022.
Last ReportedProjected for 2022
Book Value per Share 31.41  29.58 
Enterprise Value over EBIT 13.80  15.21 
Enterprise Value over EBITDA 10.91  11.54 
Price to Book Value 3.19  3.03 
Tangible Assets Book Value per Share 31.74  28.11 
Enterprise Value11.3 B10.1 B
Tangible Asset Value4.2 B3.9 B

Technical Drivers

As of the 24th of June, Amdocs shows the risk adjusted performance of 0.073, and Mean Deviation of 1.08. Amdocs Limited technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate data for nineteen technical drivers for Amdocs Limited, which can be compared to its rivals. Please confirm Amdocs Limited market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Amdocs Limited is priced correctly, providing market reflects its regular price of 84.88 per share. Given that Amdocs has jensen alpha of 0.1835, we suggest you to validate Amdocs Limited's prevailing market performance to make sure the company can sustain itself at a future point.

Amdocs Limited Price Movement Analysis

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The MESA Adaptive Moving Average indicator adapts to Amdocs Limited price movement based on the rate change of phase as measured by the Hilbert Transform Discriminator.
.

Amdocs Technical and Predictive Indicators

Amdocs Forecast Models

Amdocs time-series forecasting models is one of many Amdocs' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amdocs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Amdocs Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Amdocs stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Amdocs shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Amdocs. By using and applying Amdocs Stock analysis, traders can create a robust methodology for identifying Amdocs entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin 16.05  16.26 
EBITDA Margin 0.28  0.26 
Gross Margin 0.31  0.31 
Profit Margin 0.19  0.17 
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 29000 people.

Current Amdocs Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amdocs analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Amdocs analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
88.2Buy5Odds
Amdocs Limited current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Amdocs analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Amdocs stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Amdocs Limited, talking to its executives and customers, or listening to Amdocs conference calls.
Amdocs Analyst Advice Details

Amdocs Stock Analysis Indicators

Amdocs Limited stock analysis indicators help investors evaluate how Amdocs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Amdocs shares will generate the highest return on investment. By understating and applying Amdocs stock analysis, traders can identify Amdocs position entry and exit signals to maximize returns.
Quick Ratio1.31
Trailing Annual Dividend Rate1.41
Fifty Two Week Low68.33
Revenue Growth1.70%
Payout Ratio35.04%
Shares Short Prior Month1.9M
Average Daily Volume Last 10 Day765.45k
Average Daily Volume In Three Month665.91k
Earnings Growth-53.20%
Shares Percent Shares Out1.79%
Earnings Quarterly Growth-55.40%
Gross Margins35.01%
Short Percent Of Float2.10%
Forward Price Earnings14.11
Float Shares121.23M
Fifty Two Week High88.18
Enterprise Value To Ebitda11.95
Fifty Day Average82.37
Two Hundred Day Average78.29
Enterprise Value To Revenue2.30
Trailing Annual Dividend Yield1.82%
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.41
Market Capitalization
10 B
Quarterly Revenue Growth YOY
0.092
Return On Assets
0.0601
Return On Equity
0.16
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.